MBX vs SNA · $1.98B cap vs P/E 17, rev $1.33B
MBX Biosciences, Inc. Common Stock (MBX) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
MBX does not have a complete income-statement cache yet.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
MBX currently screens at market cap $1.98B. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the MBX and SNA stock pages for the full models.
Not investment advice.